[go: up one dir, main page]

SE9601677D0 - New use - Google Patents

New use

Info

Publication number
SE9601677D0
SE9601677D0 SE9601677A SE9601677A SE9601677D0 SE 9601677 D0 SE9601677 D0 SE 9601677D0 SE 9601677 A SE9601677 A SE 9601677A SE 9601677 A SE9601677 A SE 9601677A SE 9601677 D0 SE9601677 D0 SE 9601677D0
Authority
SE
Sweden
Prior art keywords
pct
sqdg
date
sec
pharmaceutical composition
Prior art date
Application number
SE9601677A
Other languages
English (en)
Swedish (sv)
Inventor
Mervi Tuominen-Vasaenge
Wenche Rolfsen
Lars Bohlin
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9601677(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Priority to SE9601677A priority Critical patent/SE9601677D0/xx
Publication of SE9601677D0 publication Critical patent/SE9601677D0/xx
Priority to NZ332811A priority patent/NZ332811A/en
Priority to US09/171,939 priority patent/US6124266A/en
Priority to AU27977/97A priority patent/AU707677B2/en
Priority to EP97922261A priority patent/EP0952836B1/fr
Priority to PCT/SE1997/000735 priority patent/WO1997040838A1/fr
Priority to AT97922261T priority patent/ATE284217T1/de
Priority to JP9538819A priority patent/JP2000509386A/ja
Priority to CA002253440A priority patent/CA2253440A1/fr
Priority to DE69731898T priority patent/DE69731898T2/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SE9601677A 1996-05-02 1996-05-02 New use SE9601677D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9601677A SE9601677D0 (sv) 1996-05-02 1996-05-02 New use
DE69731898T DE69731898T2 (de) 1996-05-02 1997-04-30 Verwendung von Sulphoquinovosyldiacylglycerols zur Behandlung von entzündlichen Hauterkrankungen
CA002253440A CA2253440A1 (fr) 1996-05-02 1997-04-30 Nouvelle utilisation
AU27977/97A AU707677B2 (en) 1996-05-02 1997-04-30 New use
US09/171,939 US6124266A (en) 1996-05-02 1997-04-30 Sulpholipid composition and methods for treating skin disorders
NZ332811A NZ332811A (en) 1996-05-02 1997-04-30 A topical pharmaceutical composition containing a sulphoquinovosy or sulphodeoxyhexosyl-diacyl glycerol
EP97922261A EP0952836B1 (fr) 1996-05-02 1997-04-30 Utilisation de sulphoquinovosyldiacylglycérols pour le traitement de maladies inflammatoires de la peau
PCT/SE1997/000735 WO1997040838A1 (fr) 1996-05-02 1997-04-30 Nouvelle utilisation
AT97922261T ATE284217T1 (de) 1996-05-02 1997-04-30 Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
JP9538819A JP2000509386A (ja) 1996-05-02 1997-04-30 新規な使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601677A SE9601677D0 (sv) 1996-05-02 1996-05-02 New use

Publications (1)

Publication Number Publication Date
SE9601677D0 true SE9601677D0 (sv) 1996-05-02

Family

ID=20402430

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601677A SE9601677D0 (sv) 1996-05-02 1996-05-02 New use

Country Status (10)

Country Link
US (1) US6124266A (fr)
EP (1) EP0952836B1 (fr)
JP (1) JP2000509386A (fr)
AT (1) ATE284217T1 (fr)
AU (1) AU707677B2 (fr)
CA (1) CA2253440A1 (fr)
DE (1) DE69731898T2 (fr)
NZ (1) NZ332811A (fr)
SE (1) SE9601677D0 (fr)
WO (1) WO1997040838A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69917609T2 (de) * 1998-03-05 2005-06-09 Phares Pharmaceutical Research N.V., Curaçao Arzneimittel und deren verwendung
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
KR100435417B1 (ko) 1999-02-26 2004-06-09 토요 수이산 가부시키가이샤 신규 술포람노실아실글리세롤유도체 및 그 의약으로서의용도
KR100435416B1 (ko) 1999-02-26 2004-06-09 토요 수이산 가부시키가이샤 신규 술포푸코실아실글리세롤유도체 및 그 의약으로서의용도
KR100528874B1 (ko) * 1999-02-26 2005-11-15 토요 수이산 가부시키가이샤 술포필라노실아실글리세롤유도체를 함유하는 제암제
US6518410B2 (en) 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
CA2293852A1 (fr) 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant
US20040091477A1 (en) * 2001-05-08 2004-05-13 David Haines Immunosuppresive compositions
WO2003006028A1 (fr) 2001-07-09 2003-01-23 Toyo Suisan Kaisha, Ltd. Nouveaux immunosuppresseurs
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 L−セレクチン結合阻害剤
WO2008040149A1 (fr) * 2006-09-05 2008-04-10 Dexian Dou Composition et procédé servant à traiter des troubles dermatologiques liés au système immunitaire
BRPI0718540A2 (pt) * 2006-11-07 2013-11-19 Alcon Res Ltd Método de tratamento de asma, rinite alérgica, e distúrbios de pele
EP2389816A1 (fr) 2010-05-25 2011-11-30 Nestec S.A. Composition d'antioxydant synergique
ITMI20130949A1 (it) * 2013-06-10 2014-12-11 Consiglio Nazionale Ricerche Uso e preparazione di glicolipidi come adiuvanti in vaccini
CN105131055B (zh) * 2015-08-18 2018-02-13 四川大学 一种制备硫代异鼠李糖甘油二酯的方法
CN106974925B (zh) * 2017-05-31 2021-02-05 中国海洋大学 一种硫代异鼠李糖基二酰甘油酯的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2872695B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 腎炎の治療剤
JP2872694B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 血管内血液凝固症候群の治療剤
WO1994024984A2 (fr) * 1993-04-30 1994-11-10 Winget Rodner R Compositions anti-inflammatoires contenant de l'acide eicosapentaenoique portant du monogalactosyldiacylglycerol et procedes de preparation
US5614197A (en) * 1995-02-13 1997-03-25 Industrial Farmaceutica Cantabria, S.A. Polypodium extract as photoprotectant

Also Published As

Publication number Publication date
NZ332811A (en) 2000-06-23
DE69731898D1 (de) 2005-01-13
ATE284217T1 (de) 2004-12-15
US6124266A (en) 2000-09-26
EP0952836A1 (fr) 1999-11-03
WO1997040838A1 (fr) 1997-11-06
JP2000509386A (ja) 2000-07-25
CA2253440A1 (fr) 1997-11-06
AU2797797A (en) 1997-11-19
DE69731898T2 (de) 2005-12-01
EP0952836B1 (fr) 2004-12-08
AU707677B2 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
SE9601677D0 (sv) New use
ATE253586T1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivat
DE60027016D1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ES2145922T3 (es) Compuestos espiro-azabiciclicos utiles en terapia.
MA27121A1 (fr) Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol
MXPA01006455A (es) Composiciones para el cuidado de la piel que contienen acido linoleico cis-9, trnas-11.
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
PA8432901A1 (es) Compuestos de piridilpirrol
FI934752A0 (fi) Substituerade kinuklidiner
MX9307810A (es) Heterociclicos no aromaticos sustituidos con aminometileno.
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
ES2150152T3 (es) Nuevos derivados de esteres de nitrito/nitrato esteroideos utiles como farmacos antiinflamatorios.
EP0699439A3 (fr) Traitement des maladies provoquées par des troubles des glandes sébacés avec l'emploi d'inhibiteurs de l'acyl CoA cholestérol acyl transferase
EA200301063A1 (ru) Фармацевтические агенты для лечения ганв и микроаденом
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
PE35196A1 (es) Derivado de benzamidina util como antagonista de ltb4
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
ES2135695T3 (es) Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2.
EA200001029A1 (ru) Производные гигромицина